東北大学

東北大学大学院医学系研究科
腎・膠原病・内分泌内科学分野
東北大学病院 腎・高血圧・内分泌科

論文・著書

～歴史ある論文・著書～

2018年

論文【英文】

  1. Takahashi Y, Ota H, Omura K, Dendo Y, Otani K, Matsuura T, Kitami M, Seiji K, Tezuka Y, Nezu M, Ono Y, Morimoto R, Satoh F, Takase K: Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging; Eur J Radiol 98: 150-157, 2018
  2. Minato T, Ito T, Kasahara Y, Ooshio S, Fushima T, Sekimoto A, Takahashi N, Yaegashi N, Kimura Y: Relationship between short term variability (STV) and onset of cerebral hemorrhage at ischemia–reperfusion load in fetal growth restricted (FGR) mice; Front Physiol 9: 478, 2018
  3. Parvin R, Noro E, Saito-Hakoda A, Shimada H, Suzuki S, Shimizu K, Miyachi H, Yokoyama A, Sugawara A: Inhibitory effects of a novel PPAR-𝛾 agonist MEKT1 on Pomc expression/ACTH secretion in AtT20 cells; PPAR Res 2018: 5346272, 2018
  4. Matsuzawa T, Yoshikawa T, Iida T, Kárpáti A, Kitano H, Harada R, Nakamura T, Sugawara A, Yamaguchi Y, Yanai K: Heparan sulfate in pancreatic β-cells contributes to normal glucose homeostasis by regulating insulin secretion; Biochem Biophys Res Commun 499: 688-695, 2018
  5. Noro E, Yokoyama A, Kobayashi M, Shimada H, Suzuki S, Hosokawa M, Takehara T, Parvin R, Shima H, Igarashi K, Sugawara A: Endogenous purification of NR4A2 (Nurr1) identified Poly(ADP-ribose) polymerase 1 as a prime coregulator in human adrenocortical H295R cells; Int J Mol Sci 19: pii: E1406, 2018
  6. Kobayashi T, Aida K, Takeshita A, Jimbo E, Nishida Y, Yagihashi S, Hosoi M, Fukui T, Sugawara A, Takasawa S: Crucial role of Reg I from acinar-like cell cluster touching with islets (ATLANTIS) on mitogenesis of beta cells in EMC virus-induced diabetic mice; Biochem Biophys Res Commun 503: 963-969, 2018
  7. Nanba K, Omata K, Else T, Beck PCC, Nanba AT, Turcu AF, Miller BS, Giordano TJ, Tomlins SA, Rainey WE: Targeted molecular characterization of aldosterone-producing adenomas in white Americans; J Clin Endocrinol Metab 103(10): 3869-3876, 2018
  8. Williams TA, Burrello J, Sechi LA, Fardella CE, Matrozova J, Adolf C, Baudrand R, Bernardi S, Beuschlein F, Catena C, Doumas M, Fallo F, Giacchetti G, Heinrich DA, Saint-Hilary G, Jansen PM, Januszewicz A, Kocjan T, Nishikawa T, Quinkler M, Satoh F, Umakoshi H, Widimský J Jr, Hahner S, Douma S, Stowasser M, Mulatero P, Reincke M: Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism; Hypertension 72(3): 641-649, 2018
  9. Kitawaki Y, Nakamura Y, Kubota-Nakayama F, Yamazaki Y, Miki Y, Hata S, Ise K, Kikuchi K, Morimoto R, Satoh F, Sasano H: Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma; Hum Pathol 77: 88-97, 2018
  10. Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K: Efficacy and safety of metyrosine in pheochromocytoma /paraganglioma: a multi-center trial in Japan; Endocr J 65(3): 359-371, 2018
  11. Konosu-Fukaya S, Omata K, Tezuka Y, Ono Y, Aoyama Y, Satoh F, Fujishima F, Sasano H, Nakamura Y: Catecholamine-synthesizing enzymes in pheochromocytoma and extraadrenal paraganglioma; Endocr Pathol 29(4): 302-309, 2018
  12. Narumi K, Mishima E, Akiyama Y, Matsuhashi T, Nakamichi T, Kisu K, Nishiyama S, Ikenouchi H, Kikuchi A, Izumi R, Miyazaki M, Abe T, Sato H, Ito S: Focal segmental glomerulosclerosis associated with chronic progressive external ophthalmoplegia and mitochondrial DNA A3243G mutation; Nephron 138(3): 243-248, 2018
  13. Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, Takagi K, Mizumoto S, Yamada S, van Kuppevelt TH, Yokoyama A, Matsusaka T, Sato H, Ito S, Sugawara A: The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion; Nephrol Dial Transplant 33(1): 26-33, 2018
  14. Oba-Yabana I, Mori T, Takahashi C, Hirose T, Ohsaki Y, Kinugasa S, Muroya Y, Sato E, Nguyen G, Piedagnel R, Ronco PM, Totsune K, Ito S: Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells; Sci Rep 8(1): 2648, 2018
  15. Kashihara N, Nangaku M, Ito S, Nishiyama A, Harris D: The Sendai declaration for the eradication of kidney disease; Clin Exp Nephrol 22(1): 1-2, 2018
  16. Nakayama M, Itami N, Suzuki H, Hamada H, Yamamoto R, Tsunoda K, Osaka N, Nakano H, Maruyama Y, Kabayama S, Nakazawa R, Miyazaki M, Ito S: Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study; Sci Rep 8(1): 254, 2018
  17. Narumi K, Sato E, Hirose T, Yamamoto T, Nakamichi T, Miyazaki M, Sato H, Ito S: (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion; Sci Rep 8(1): 16, 2018
  18. Oe Y, Ko M, Fushima T, Sato E, Karumanchi SA, Sato H, Sugawara J, Ito S, Takahashi N: Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase; Sci Rep 8(1): 102, 2018
  19. Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, Ito S, Hasebe N, Webb DJ: Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension; J Hypertens 36(3): 451-461, 2018
  20. Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, Rizzoni D, Rossignol P, Ruilope LM, van den Meiracker AH, Ito S, Hasebe N, Webb DJ: Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension; J Hypertens 36(3): 462-471, 2018
  21. Takahashi N, Li F, Fushima T, Oyanagi G, Sato E, Oe Y, Sekimoto A, Saigusa D, Sato H, Ito S: Vitamin B3 nicotinamide: A promising candidate for treating preeclampsia and improving fetal growth; Tohoku J Exp Med 244: 243-248, 2018
  22. Iwai T, Miyazaki M, Yamada G, Nakayama M, Yamamoto T, Satoh M, Sato H, Ito S: Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study; Clin Exp Nephrol 22(2): 328-336, 2018
  23. Sato E, Wang AY, Satoh M, Nishikiori Y, Oba-Yabana I, Yoshida M, Sato H, Ito S, Hida W, Mori T: Urinary angiotensinogen excretion level is associated with elevated blood pressure in the normotensive general population; Am J Hypertens 31(6): 742-749, 2018
  24. Morimoto R, Omata K, Ito S, Satoh F: Progress in the management of primary aldosteronism; Am J Hypertens 31(5): 522-531, 2018
  25. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators: Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: Report of a randomized study; Diabetes Care 41(6): 1275-1284, 2018
  26. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J: Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate; Kidney Int 93(6): 1442-1451, 2018
  27. Ogawa S, Shimizu M, Nako K, Okamura M, Ito S: Decreased glycaemia with renal failure in diabetes betides in relation to the change in renal glutamate metabolism; Journal of Clinical & Experimental Nephrology 3(1): 55, 2018
  28. Yamazaki Y, Omata K, Tezuka Y, Ono Y, Morimoto R, Adachi Y, Ise K, Nakamura Y, Gomez-Sanchez CE, Shibahara Y, Kitamoto T, Nishikawa T, Ito S, Satoh F, Sasano H: Tumor cell subtypes based on the intracellular hormonal activity in KCNJ5-Mutated aldosterone-producing adenoma; Hypertension 72(3): 632-640, 2018
  29. Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE: Cellular and genetic causes of idiopathic hyperaldosteronism; Hypertension 72(4): 874-880, 2018
  30. Mishima E, Suzuki T, Takeuchi Y, Seiji K, Fukuhara N, Takase K, Harigae H, Abe T, Ito S: Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review; J Clin Hypertens (Greenwich) 20(4): 798-804, 2018
  31. Nezu M, Kudo M, Morimoto R, Ono Y, Omata K, Tezuka Y, Igarashi Y, Hitachi S, Takase K, Ito S, Satoh F: Effects of surgical treatment for acromegaly on knee MRI structural features; Endocr J 65(10): 991-999, 2018
  32. Mishima E, Umezawa S, Suzuki T, Fujimura M, Abe M, Hashimoto J, Abe T, Ito S: Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians; Clin Exp Nephrol 22(6): 1294-1299, 2018
  33. Mao YH, Xu LN, Weng QH, Li XY, Zhao B, Nie JJ, Hu JH, Zhang LQ, Chen Z, Zuo MZ, Ito S, Cai JP: The ratio of plasma and urinary 8-oxo-Gsn could be a novel evaluation index for patients with chronic kidney disease; Oxid Med Cell Longev 2018: 4237812, 2018
  34. Mishima E, Fukuda S, Kanemitsu Y, Saigusa D, Mukawa C, Asaji K, Matsumoto Y, Tsukamoto H, Tachikawa T, Tsukimi T, Fukuda NN, Ho HJ, Kikuchi K, Suzuki C, Nanto F, Suzuki T, Ito S, Soga T, Tomioka Y, Abe T: Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model; Am J Physiol Renal Physiol 315(4): F824-F833, 2018
  35. Shimada S, Hirose T, Takahashi C, Sato E, Kinugasa S, Ohsaki Y, Kisu K, Sato H, Ito S, Mori T: Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model; Sci Rep 8(1): 16808, 2018
  36. Eguchi K, Miyashita H, Takenaka T, Tabara Y, Tomiyama H, Dohi Y, Hashimoto J, Ohkubo T, Ohta Y, Hirooka Y, Kohara K, Ito S, Kawano Y, Sunagawa K, Suzuki H, Imai Y, Kario K, Takazawa K, Yamashina A, Shimada K; ABC-J II Investigator Group: High central blood pressure is associated with incident cardiovascular events in treated hypertensives: the ABC-J II Study; Hypertens Res 41(11): 947-956, 2018
  37. Nakayama M, Watanabe K, Hayashi Y, Terawaki H, Zhu WJ, Kabayama S, Ito S: Translational research of peritoneal dialysis solution with dissolved molecular hydrogen; Contrib Nephrol 196: 162-170, 2018
  38. Ogawa S, Nako K, Ito S: Effects of sodium-glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretion; Endocrinol Diab Metab 2018: e00044, 2018
  39. Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH future plan working group and executive board members: The Japanese Society of Hypertension-Digest of plan for the future; Hypertens Res 41(12): 989-990, 2018
  40. Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators: Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: A randomized trial; Am J Kidney Dis 72(6): 798-810, 2018
  41. Shimada S, Nakamichi T, Yamada G, Narumi K, Usubuchi H, Yamamoto T, Ichikawa S, Fukuhara N, Miyazaki M, Harigae H, Sato H, Ito S: Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma; CEN Case Rep 7: 248-252, 2018
  42. Hashimoto J, Westerhof BE, Ito S: Carotid flow augmentation, Arterial aging, and cerebral white matter hyperintensities; Arterioscler Thromb Vasc Biol 38(12): 2843-2853, 2018
  43. Mori T, Sato S, Oba-Yabana I, Hirose T, Kinugasa S, Muroya Y, Ota K, Nakayama S, Nakamura H, Tani J, Takahashi C, Ito S: Better healing of the exit site with negative-pressure wound therapy; Adv Perit Dial 34: 53-57, 2018

論文【邦文】

  1. 鈴木健弘、阿部高明：ミトコンドリアをターゲットとした腎臓病治療；Kidney Metab Bone Dis 31(1); 67-74, 2018
  2. 熊倉慧、伊藤貞嘉：心臓と腎臓のクロストーク；臨床検査62(1); 58-64, 2018
  3. 佐藤文俊、手塚雄太、尾股慧、小野美澄、五十嵐康宏、森本玲、工藤正孝、伊藤貞嘉：副腎疾患の内科的診断治療；臨床画像34(3); 317-325, 2018
  4. 森本玲、伊藤貞嘉：内分泌性高血圧症としての睡眠時無呼吸症候群の病態と治療；日本内科学会雑誌107(4); 696-702, 2018
  5. 佐藤文俊、手塚雄太、尾股慧、小野美澄、五十嵐康宏、森本玲、工藤正孝、笹野公伸、伊藤貞嘉：原発性アルドステロン症；血圧25(4); 235-239, 2018
  6. 鈴木健弘、阿部高明：酸化ストレスと腎障害；実験医学36(5); 821-826, 2018
  7. 伊藤貞嘉：2017AHA/ACCガイドラインのポイント；日本臨牀76(8); 1313-1319, 2018

著書【分担執筆】

  1. 小川晋：腎機能低下例におけるSGLT2阻害薬の安全性をみる；SGLT2阻害薬のすべて第2版；稲垣暢也編集；先端医学社；50-55, 2018年5月
  2. 伊藤貞嘉：利尿薬；治療薬 UP-TO-DATE 2018；メディカルレビュー社；250-252, 2018.1.20
  3. 伊藤貞嘉：腎臓の構造、腎機能調節、腎臓と血管；腎臓リハビリテーション第2版；医歯薬出版株式会社；46-52, 108-111, 2018.10.5
TOP